RNAZ CIK: 1829635

Transcode Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.15
FY22:
−18.6
FY23:
−19.4
FY24:
−15.7
FY25:
−28.0
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−16.8
FY25:
−34.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.84
FY22:
−17.6
FY23:
−18.5
FY24:
−16.8
FY25:
−34.7

All amounts in millions USD Data source:SEC EDGAR